Anesthesia Considerations for Patients on Tricyclic Antidepressants
Continue tricyclic antidepressants (TCAs) perioperatively but prepare for severe hypotension after induction that requires direct-acting vasopressors (noradrenaline or adrenaline) rather than indirect agents like ephedrine or phenylephrine. 1
Critical Hemodynamic Management
Hypotension Risk and Treatment Algorithm
TCAs cause severe refractory hypotension after anesthesia induction (median onset 7.5 minutes post-induction, with systolic BP dropping below 75 mmHg) that does not respond to standard indirect-acting vasopressors 1
Have noradrenaline or adrenaline immediately available before induction—80% of TCA patients require these direct-acting agents to restore blood pressure 1
Avoid relying on ephedrine or phenylephrine as first-line agents, as they demonstrate poor efficacy in TCA patients due to depleted norepinephrine stores at nerve terminals 1, 2
This hypotension can mimic anaphylaxis (rapid onset, resistance to usual treatments) but occurs without tryptase elevation—do not delay appropriate vasopressor treatment while investigating for allergy 1
Mechanism of Hypotension
TCAs deplete norepinephrine stores at sympathetic nerve terminals through chronic reuptake inhibition, rendering indirect-acting vasopressors (which rely on endogenous norepinephrine release) ineffective 2
Direct-acting alpha-adrenergic agonists (noradrenaline, adrenaline) bypass this mechanism and restore vascular tone effectively 1, 2
Serotonin Syndrome Risk
Avoid combining TCAs with serotonergic opioids and other serotonergic agents perioperatively to prevent potentially fatal serotonin syndrome 3
High-Risk Drug Combinations
Tertiary amine TCAs (amitriptyline, imipramine, clomipramine) combined with serotonergic opioids (meperidine, fentanyl, methadone, tramadol, tapentadol) significantly increase serotonin syndrome risk 3
Additional perioperative serotonergic agents to avoid or use cautiously: ondansetron, granisetron, metoclopramide, linezolid 3
Serotonin syndrome presents with neuroexcitatory symptoms, autonomic dysfunction, and neuromuscular abnormalities—maintain high clinical suspicion when multiple serotonergic agents are used 3
Perioperative Continuation vs. Discontinuation
Continue TCAs perioperatively rather than discontinuing them 4, 5
Rationale for Continuation
Abrupt discontinuation risks psychiatric relapse or recurrence, requiring intensive psychiatric intervention 6
The risks of withdrawal and psychiatric decompensation generally outweigh anesthetic risks when proper precautions are taken 4, 5
If discontinuation is absolutely necessary (rare circumstances), requires psychiatric consultation and cannot be done acutely 6
Specific Monitoring Requirements
Cardiovascular Vigilance
Implement strict hemodynamic monitoring from induction through emergence, with particular attention during the first 10-15 minutes post-induction 1, 2
Monitor for arrhythmias, as TCAs have quinidine-like effects on cardiac conduction 4, 5
Patients with systemic disorders on TCAs require especially intensive cardiovascular observation 6
Drug Interaction Awareness
Review all perioperative medications for potential interactions, particularly QT-prolonging agents and serotonergic drugs 3, 4
TCAs have multiple drug-drug interactions affecting cardiac conduction, serotonin levels, and autonomic function 4, 5
Practical Pitfalls to Avoid
Do not waste time with escalating doses of ephedrine or phenylephrine—move directly to noradrenaline or adrenaline when hypotension occurs in TCA patients 1, 2
Do not mistake TCA-induced hypotension for anaphylaxis—absence of tryptase elevation and monosymptomatic presentation (hypotension only, no rash/bronchospasm) distinguish this phenomenon 1
Do not discontinue TCAs preoperatively without psychiatric consultation—the psychiatric risks typically outweigh anesthetic concerns 6
Do not combine multiple serotonergic agents without considering cumulative risk—even "routine" antiemetics like ondansetron contribute to serotonin syndrome risk 3